Phosphorylated sulfonimidamides (SIAPhos) undergo ion exchange reactions with cationic complexes, [Rh(cod) 2 BF 4 ] and [Ir(cod) 2 BarF], or neutral complexes [Rh(cod)Cl] 2 and [Ir(cod)Cl] 2 , leading to unprecedented neutral complexes with P‐N‐S‐N chelates. Use of the resulting neutral iridium complexes in asymmetric hydrogenation reactions of tri‐ and tetrasubstituted enamides leads to products with high enantioselectivities (up to 92% ee ).
No takes yet. Share an insight, caveat, or question.
Patureau et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: